SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-17-001632
Filing Date
2017-02-15
Accepted
2017-02-15 09:19:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G/A 144008
2 ex1.htm EX-1 11698
  Complete submission text file 0001493152-17-001632.txt   157365
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44055 | Film No.: 17613226
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A